Chemotherapy Treated Cells
Chemotherapy Treated Cells - Related Videos
07:42
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
0 Views •
Cited by 28 •
2012
This abstract describes a novel method to assess the development of neurotoxicity in patients receiving chemotherapy treatment. While conventional assessment methods are limited in their ability to detect early changes in nerve function, nerve excitability techniques provide early identification of patients at risk of severe neurotoxicity and insight into pathophysiology.
05:06
Alkaline Single Cell Gel Electrophoresis: A Sensitive Technique for Quantitative Estimation of DNA Damage in Individual Cancer Cells Following Chemotherapy
0 Views •
2025
In this video, we demonstrate an alkaline single-cell electrophoresis assay to quantify both single- and double-strand DNA breaks in doxorubicin-treated cells. Alkaline conditions disrupt the hydrogen bonds between DNA base pairs, resulting in the complete unwinding and separation of DNA strands. This allows differential migration of undamaged and damaged DNA fragments in agarose gel upon electrophoresis, revealing a comet-shaped structure of slowly migrating undamaged DNA forming the circular...
08:41
Modeling Chemotherapy Resistant Leukemia In Vitro
0 Views •
Cited by 15 •
2016
The current report summarizes a protocol that can be utilized to model the influence of the bone marrow microenvironment niche on leukemic cells with emphasis placed on enrichment of the most chemoresistant subpopulation.
08:14
Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)
0 Views •
Cited by 59 •
2017
Tumor Treating Fields (TTFields) are an effective anti-tumor treatment modality delivered via the continuous, noninvasive application of low-intensity, intermediate-frequency, alternating electric fields. TTFields application to cell lines using a TTFields in vitro application system allows for the determination of the optimal frequency that leads to the highest reduction in cell counts.
08:52
Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
0 Views •
Cited by 49 •
2011
A rapid, simple and cost-effective protocol for the generation of donor-derived multivirus-specific CTLs (rCTL) for infusion to allogeneic hematopoietic stem cell transplant (HSCT) recipients at risk of developing CMV, Adv or EBV infections. This manufacturing process is GMP-compliant and should ensure the broader implementation of T-cell immunotherapy beyond specialized centers.
FAQs
Chemotherapy-treated cells can respond differently even when exposed to the same agent because concentration, exposure time, and cell type alter the outcome. These variables may change the extent of survival loss, growth inhibition, or functional disruption. Keeping treatment conditions explicit allows researchers to relate observed cellular behavior to the chemical treatment rather than treating all responses as equivalent.
Anticancer drugs can affect cells through several connected routes: DNA damage, interference with DNA replication, disruption of cell division, or activation of programmed cell death. Examining which response accompanies treatment helps researchers distinguish whether cells fail to proliferate, lose viability, or undergo an organized death process. This mechanistic view supports interpretation of cellular outcomes beyond a single survival measurement.
Comparing cellular responses across treatment conditions can show whether a model remains sensitive or exhibits a reduced response, providing evidence relevant to drug resistance. The same framework supports combination-therapy studies, in which researchers compare outcomes produced by different chemical treatment arrangements. Such comparisons connect treatment conditions with changes in survival, growth, or molecular behavior.
A treatment study should specify the chemical agent, its concentration, exposure time, and the cell type examined. After exposure, researchers assess selected outcomes such as survival, growth, cell-cycle changes, cytotoxicity, or programmed cell death. Consistent reporting of these conditions makes it possible to compare responses among cell models or experimental treatments.
Measurements can focus on cytotoxicity, survival, growth, cell-cycle behavior, programmed cell death, drug resistance, or molecular outcomes. These readouts answer different questions: some indicate whether treatment harms cells, whereas others reveal how cellular processes change. Multiple readouts can connect a visible treatment response with a possible underlying mechanism.
They provide an experimental system for linking chemical treatment conditions with cellular and molecular responses. Researchers apply them in cancer biology, drug development, and evaluation of combination therapies, while comparisons across cell types or models can reveal differences in treatment response. The resulting data help characterize candidate treatments and investigate how cellular behavior changes under anticancer drug exposure.